[Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers]. 1990

S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
Service de Médecine Interne de la Pitié, Groupe Hospitalier Pitié-Salpêtrière, Paris.

A cross-over, double-blind, randomized trial with 8 healthy volunteers was undertaken to compare prednisolone and prednisone pharmacokinetics after a single oral dose (1 mg/kg) of prednisone (Cortancyl) and prednisolone sodium metasulfobenzoate (Solupred). Maximum prednisolone concentrations measured after ingestion of prednisone are higher (535 +/- 32 ng/ml) and occur earlier than after taking prednisolone sodium metasulfobenzoate (198 +/- 114 ng/ml) (p less than 0.001). The areas under the curve are significantly larger after prednisone than after prednisolone sodium metasulfobenzoate (p less than 0.02). These findings suggest a decreased systemic availability of prednisolone after prednisolone sodium metasulfobenzoate (Solupred) administration and show, from a strictly pharmacokinetic point of view, that equimolar doses of prednisone and prednisolone sodium metasulfobenzoate are not equivalent therapies.

UI MeSH Term Description Entries
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
August 2013, Therapeutic drug monitoring,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
June 1999, Journal of clinical pharmacology,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
February 1980, Journal of pharmacokinetics and biopharmaceutics,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
December 2005, Journal of acquired immune deficiency syndromes (1999),
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 1984, European journal of clinical pharmacology,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 1981, Revista medica de Chile,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 1986, European journal of clinical pharmacology,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 2021, Frontiers in pharmacology,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 1988, Clinical neuropharmacology,
S D Etienne, and V Vandermeersch, and O Chosidow, and C Vu-Thi-My-Le, and P Godeau, and B Diquet, and S Herson
January 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!